ZIOPHARM Oncology

ZIOPHARM Oncology

ZIOPHARM Oncology is a biotechnology company developing cancer therapies founded in 2005.

All edits by  Rahul Duggal 

Edits on 12 Sep, 2019
Rahul Duggal
Rahul Duggal approved a suggestion from Golden's AI on 12 Sep, 2019
Edits made to:
Article (+13/-13 characters)
Article

Ziopharm is developing immunotherapies using Controlled IL-12, which weaponizes the existing immune systemimmune system and Sleeping Beauty-modified T cells, which introduces new immune system elements to fight cancer.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.